Test-retest reliability of UPDRS-III dyskinesia scales, and timed motor test in patients with advanced Parkinson's disease: An argument against multiple baseline assessments

Movement Disorders

Volumn 19, Issue 9, 2004, Pages 1079-1084

  Metman, Leo Verhagen ^a   Myre, Brian ^a   Verwey, Niek ^a   Hassin Baer, Sharon ^b   Arzbaecher, Jean ^c   Sierens, Diane ^c   Bakay, Roy ^c  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b SHEBA MEDICAL CENTER   (Israel)

^c Chicago Institute of Neurosurgery and Neuroresearch   (United States)

Author keywords

CAPIT; CAPSIT; Parkinson's disease; Test retest reliability; UPDRS

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG USE; DRUG WITHDRAWAL; DYSKINESIA; FEMALE; HUMAN; MALE; MEDICAL ASSESSMENT; MOTOR PERFORMANCE; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RATING SCALE; RELIABILITY; SCORING SYSTEM; SUBTHALAMIC NUCLEUS; TIME; WILCOXON SIGNED RANKS TEST;

DYSKINESIAS; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PSYCHOMOTOR PERFORMANCE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 4644264941     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20101     Document Type: Article

References (15)

1. Fahn S, Elton RL, the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne D, Goldstein M, editors. Recent developments in Parkinson's disease. Florham Park, NJ: Macmillan Health Care Information; 1987. p 153-164.
2. Richards M, Marder K, Cote L, Mayeux R. Interrater reliability of the Unified Parkinson's Disease Rating Scale motor examination. Mov Disord 1994;9:89-91.
3. van Hilten JJ, van der Zwan AD, Zwinderman AH, Roos RA. Rating impairment and disability in Parkinson's disease: evaluation of the Unified Parkinson's Disease Rating Scale. Mov Disord 1994;9:84-88.
4. Martinez-Martin P, Gil-Nagel A, Gracia LM, Gomez JB, Martinez-Sarries J, Bermejo F. Unified Parkinson's Disease Rating Scale characteristics and structure. The Cooperative Multicentric Group. Mov Disord 1994;9:76-83.
5. Stebbins GT, Goetz CG. Factor structure of the Unified Parkinson's Disease Rating Scale: motor examination section. Mov Disord 1998;13:633-636.
6. Siderowf A, McDermott M, Kieburtz K, Blindauer K, Plumb S, Shoulson I, the Parkinson Study Group. Test-retest reliability of the Unified Parkinson's Disease Rating Scale in patients with early Parkinson's disease: results from a multicenter clinical trial. Mov Disord 2002;17:758-763.
7. Langston JW, Widner H, Goetz CG, Brooks D, Fahn S, Freeman T, Watts R. Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 1992;7:2-13.
8. Defer GL, Widner H, Marie RM, Remy P, Levivier M. Core assessment program for surgical interventional therapies in Parkinson's disease (CAPSIT-PD). Mov Disord 1999;14:572-584.
9. Guy W, editor. ECDEU assessment manual for psychopharmacology. Washington: Government Printing Office; 1976. p 534-537.
10. Goetz CG, Stebbins GT, Shale HM, Lang AE, Chernik DA, Chmura TA, Ahlskog JE, Dorflinger EE. Utility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessment. Mov Disord 1994;9:390-394.
11. Goetz CG, Stebbins GT, Chmura TA, Fahn S, Klawans HL, Marsden CD. Teaching tape for the motor section of the Unified Parkinson's Disease Rating Scale. Mov Disord 1995;10:263-266.
12. Fleiss JL. The measurement of interrater agreement. In: Fleiss JL, editor. Statistical methods for rates and proportions. New York: Wiley and Sons; 1981. p 212-236.
13. Nutt JG, Woodward WR. Levodopa pharmacokinetics and pharmacodynamics in fluctuating parkinsonian patients. Neurology 1986;36:739-774.
14. Verhagen Metman L, van den Munckhof P, Klaassen AA, Blanchet P, Mouradian MM, Chase TN. Effects of supra-threshold levodopa doses on dyskinesias in advanced Parkinson's disease. Neurology 1997;49:711-713.
15. Lang AE, Widner H. Deep brain stimulation for Parkinson's disease: patient selection and evaluation. Mov Disord 2002; 17(Suppl.):94-101.